source
- Caldera and Vidya secure $478M via reverse mergers to go publicCaldera Therapeutics, a U.S. bispecific antibody biotech, announced a reverse merger with Nasdaq-listed Synlogic to become a public company. The deal includes a $278 million private placement from…
- Biogen's $5.6B Apellis Purchase Boosts Q2 Revenue Above ForecastsBiogen began reporting revenue from its $5.6 billion acquisition of Apellis in the second quarter, pushing earnings above analysts' consensus estimates. CEO Chris Viehbacher said the company will…